Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 791-800 of 1772 for cancer

Edit search filters
  1. Tucatinib And Trastuzumab For Patients With HER2-positive Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. S1011 Standard Or Extended Pelvic Lymphadenectomy In Treating Patients Undergoing Surgery For Invasive Bladder Cancer

    Rochester, MN

  3. A Study Of Pembrolizumab And Ruxolitinib Phosphate For Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer

    Scottsdale/Phoenix, AZ

  4. A Study To Evaluate A Resilient Living Program For Patients With Advancer Cancer And Their Caregivers

    Rochester, MN

  5. Veliparib And Combination Chemotherapy In Treating Patient With Locally Advanced Rectal Cancer

    Jacksonville, FL, Rochester, MN

  6. A Study To Compare Trilaciclib Versus Placebo In Patients Receiving FOLFOXIRI/Bevacizumab For Metastatic Colorectal Cancer

    Rochester, MN

  7. Proton Therapy Vs. IMRT For Low Or Intermediate Risk Prostate Cancer

    Rochester, MN

  8. VSV-hIFNbeta-NIS In Treating Patients With Stage IV Or Recurrent Endometrial Cancer

    Rochester, MN

  9. A Study Of Grapiprant And Pembrolizumab In Patients With Advanced Or Progressive MSS Colorectal Cancer

    Scottsdale/Phoenix, AZ

  10. A Study To Evaluate Encorafenib Plus Cetuximab With/without Chemotherapy To Treat Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer